000			01449 a2200373 4500
005			20250513104037.0
264		0	_c19961210
008			199612s 0 0 eng d
022			_a0022-5223
024	7		_a10.1016/S0022-5223(96)70154-X _2doi
040			_aNLM _beng _cNLM
100	1		_aNguyen, D M
245	0	0	_aGene therapy for lung cancer: enhancement of tumor suppression by a combination of sequential systemic cisplatin and adenovirus-mediated p53 gene transfer. _h[electronic resource]
260			_bThe Journal of thoracic and cardiovascular surgery _cNov 1996
300			_a1372-6; discussion 1376-7 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aAnimals
650	0	4	_aAntineoplastic Agents _xtherapeutic use
650	0	4	_aApoptosis
650	0	4	_aCisplatin _xtherapeutic use
650	0	4	_aGene Expression
650	0	4	_aGene Transfer Techniques
650	0	4	_aGenes, p53
650	0	4	_aGenetic Therapy
650	0	4	_aLung Neoplasms _xpathology
650	0	4	_aMice
650	0	4	_aTumor Cells, Cultured
700	1		_aSpitz, F R
700	1		_aYen, N
700	1		_aCristiano, R J
700	1		_aRoth, J A
773	0		_tThe Journal of thoracic and cardiovascular surgery _gvol. 112 _gno. 5 _gp. 1372-6; discussion 1376-7
856	4	0	_uhttps://doi.org/10.1016/S0022-5223(96)70154-X _zAvailable from publisher's website
999			_c8903836 _d8903836